QQ客服 官方微博 反馈留言

浏览/检索结果: 共11条，第1-10条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 IMPACT OF SPLENOMEGALY ON MPN SYMPTOMS AND ASSOCIATION WITH CLINICAL FEATURES: AN ANALYSIS BY THE MPN QUALITY OF LIFE INTERNATIONAL STUDY GROUP 会议论文 HAEMATOLOGICA, 2016-06-01 作者:  Geyer, H.;  Scherber, R.;  Kosiorek, H.;  Dueck, A.;  Kiladjian, J. J. 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/04 DEVELOPMENT OF AN MF PATIENT REPORTED OUTCOME (PRO) TOOL FOR FDA QUALIFICATION: COMPREHENSIVE LITERATURE SEARCH AND PHYSICIAN COGNITIVE DEBRIEFING RESULTS 会议论文 HAEMATOLOGICA, 2016-06-01 作者:  Geyer, H.;  Kosiorek, H.;  Dueck, A.;  Slot, S.;  Zweegman, S. 收藏  |  浏览/下载：11/0  |  提交时间：2020/01/04 SYMPTOMS, RISK CLASSIFICATION, AND SPLEEN SIZE IN JAK2 INHIBITOR-NAIVE MYELOFIBROSIS: IMPLICATIONS FOR JAK2 INHIBITOR TREATMENT 会议论文 HAEMATOLOGICA, 2016-06-01 作者:  Scherber, R.;  Dueck, A.;  Geyer, H.;  Kosiorek, H.;  Kiladjian, J. J. 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 DEVELOPMENT OF AN MF PATIENT REPORTED OUTCOME (PRO) TOOL FOR FDA QUALIFICATION: COMPREHENSIVE LITERATURE SEARCH AND PHYSICIAN COGNITIVE DEBRIEFING RESULTS 期刊论文 2016, 卷号: 101, 页码: 564-564 作者:  Geyer, H.;  Kosiorek, H.;  Dueck, A.;  Slot, S.;  Zweegman, S. 收藏  |  浏览/下载：9/0  |  提交时间：2020/01/04 SYMPTOMS, RISK CLASSIFICATION, AND SPLEEN SIZE IN JAK2 INHIBITOR-NAIVE MYELOFIBROSIS: IMPLICATIONS FOR JAK2 INHIBITOR TREATMENT 期刊论文 2016, 卷号: 101, 页码: 557-558 作者:  Scherber, R.;  Dueck, A.;  Geyer, H.;  Kosiorek, H.;  Kiladjian, J. J. 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 IMPACT OF SPLENOMEGALY ON MPN SYMPTOMS AND ASSOCIATION WITH CLINICAL FEATURES: AN ANALYSIS BY THE MPN QUALITY OF LIFE INTERNATIONAL STUDY GROUP 期刊论文 2016, 卷号: 101, 页码: 555-555 作者:  Geyer, H.;  Scherber, R.;  Kosiorek, H.;  Dueck, A.;  Kiladjian, J. J. 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/04 PRIMARY MYELOFIBROSIS, POST-ET AND POST-PV MYELOFIBROSIS HAVE DISTINCT CLINICAL PROFILES AND SYMPTOMATIC BURDENS: AN ANALYSIS BY THE MPN QUALITY OF LIFE INTERNATIONAL STUDY GROUP (MPN-QOL ISG) 会议论文 HAEMATOLOGICA, 2015-06-01 作者:  Geyer, H.;  Kosiorek, H.;  Scherber, R.;  Dueck, A.;  Jean-Jacques, K. 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13 PRIMARY MYELOFIBROSIS, POST-ET AND POST-PV MYELOFIBROSIS HAVE DISTINCT CLINICAL PROFILES AND SYMPTOMATIC BURDENS: AN ANALYSIS BY THE MPN QUALITY OF LIFE INTERNATIONAL STUDY GROUP (MPN-QOL ISG) 期刊论文 2015, 卷号: 100, 页码: 261-262 作者:  Geyer, H.;  Kosiorek, H.;  Scherber, R.;  Dueck, A.;  Jean-Jacques, K. 收藏  |  浏览/下载：9/0  |  提交时间：2020/01/13 GENDER DIFFERENCES AND MPN SYMPTOM BURDEN: AN ANALYSIS BY THE MPN QUALITY OF LIFE INTERNATIONAL STUDY GROUP (MPN-QOL ISG) 会议论文 HAEMATOLOGICA, 2014-06-01 作者:  Geyer, H.;  Emanuel, R.;  Dueck, A.;  Kiladjian, J. J.;  Xiao, Z. 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 GENDER DIFFERENCES AND MPN SYMPTOM BURDEN: AN ANALYSIS BY THE MPN QUALITY OF LIFE INTERNATIONAL STUDY GROUP (MPN-QOL ISG) 期刊论文 2014, 卷号: 99, 页码: 396-397 作者:  Geyer, H.;  Emanuel, R.;  Dueck, A.;  Kiladjian, J. J.;  Xiao, Z. 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13